Testing antihistamines and amantadine for COVID-19
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study looks at how ongoing antihistamines or amantadine treatment affects the course of COVID-19. If you already take one of these medicines regularly, the study may help understand whether it offers any benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You take antihistamines regularly (every day or as prescribed) for a long time
- OR you take amantadine regularly for a long time
- You must be able to continue your chronic medicine as instructed for the study
- You have (or are being treated for) COVID-19 as part of the study enrollment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This trial tests whether the medicine nitazoxanide, taken as a pill, can help people with mild COVID-19 or flu feel better faster and prevent complications. It is designed for people who are generally healthy and can be treated at home.
This early-phase trial tests a new drug (called B10-FC) to see if it's safe and how the body processes it. It is given once to healthy adults, and later to people with mild or moderate COVID-19 who are at higher risk of getting very sick.
This trial tests a combination of two traditional Chinese herbal formulas (Yinqiaosan and Maxingganshitang) to see if they can help people with mild to moderate COVID-19 recover faster. It's for adults who have had symptoms for no more than 3 days and have been diagnosed with a specific Chinese medicine pattern.
This trial tests whether Astepro nasal spray can help people with mild or no COVID-19 symptoms recover faster. If you have tested positive and are vaccinated, you may qualify.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.